Stem Cell Manufacturing Market Research Report Information by Product (Stem Cell Lines [Mesenchymal Stem Cells (MSCs), Induced Pluripotent Stem Cell (iPSC), Embryonic Stem Cell (ESC), Hematopoietic Stem Cells (HSCs), and Others], Instruments [Bioreactors, Incubators, Cell Sorters, and Others], Culture Media, and Consumables), by Application (Research, Target Identification, Stem Cell-Based Therapy [Autologous and Allogeneic], and Cell & Tissue Banking), by End User (Pharmaceutical & Biotechnology Companies, Hospitals, Stem Cell Banks, and O

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 GROWING AWARENESS REGARDING THE USAGE OF STEM CELLS FOR TREATING VARIOUS DISEASES

4.2.2 INCREASING PREVALENCE OF RARE DISEASES

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN STEM CELL MANUFACTURING

4.3 RESTRAINTS

4.3.1 RISKS ASSOCIATED WITH UNPROVEN STEM CELL TREATMENTS

4.3.2 HIGHER OPERATIONAL COSTS ASSOCIATED WITH STEM CELL MANUFACTURING AND BANKING

4.4 OPPORTUNITIES

4.4.1 INCREASING PUBLIC AND PRIVATE FUNDING FOR STEM CELL-BASED RESEARCH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES REVIEW

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 BARGAINING POWER OF BUYERS

5.2.4 INTENSITY OF RIVALRY

5.2.5 THREAT OF SUBSTITUTES

5.3 IMPACT OF COVID-19

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 IMPACT ON DEMAND-SUPPLY GAP ANALYSIS

5.3.4 IMPACT ON R&D

6 GLOBAL STEM CELL MANUFACTURING MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 STEM CELL LINES

6.3 INSTRUMENTS

6.4 CULTURE MEDIA

6.5 CONSUMABLES

7 GLOBAL STEM CELL MANUFACTURING MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 RESEARCH

7.3 TARGET IDENTIFICATION

7.4 STEM CELL-BASED THERAPY

7.5 CELL AND TISSUE BANKING

8 GLOBAL STEM CELL MANUFACTURING MARKET, BY END USER

8.1 OVERVIEW

8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

8.3 HOSPITALS

8.4 STEM CELL BANKS

8.5 OTHERS

9 GLOBAL STEM CELL MANUFACTURING MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 INDIA

9.4.3 JAPAN

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN STEM CELL MANUFACTURING MARKET

10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN STEM CELL MANUFACTURING MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES

10.6.2 PARTNERSHIP/COLLABORATION

10.6.3 BUSINESS EXPANSIONS/AGREEMENTS

10.6.4 MERGERS & ACQUISITIONS

11 COMPANY PROFILES

11.1 ABBVIE, INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 BIO-RAD LABORATORIES, INC.

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 FUJIFILM HOLDINGS CORPORATION (FUJIFILM CELLULAR DYNAMICS, INC.)

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 KEY STRATEGIES

11.4 BECTON DICKINSON AND COMPANY

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL ANALYSIS

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 THERMO FISHER SCIENTIFIC INC.

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL ANALYSIS

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 LONZA GROUP

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL ANALYSIS

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 BRISTOL-MYERS SQUIBB COMPANY

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 GLAXOSMITHKLINE PLC

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 SARTORIUS AG

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 MERCK KGAA

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 TAKEDA PHARMACEUTICAL COMPANY LIMITED

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 SWOT ANALYSIS

11.11.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CULTURE MEDIA, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CONSUMABLES, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR RESEARCH, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR CELL AND TISSUE BANKING, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR STEM CELL BANKS, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: STEM CELL MANUFACTURING MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 24 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 25 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 27 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 28 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 29 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 30 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 31 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 32 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 33 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 34 US: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 36 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 37 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 38 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 39 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 40 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 41 EUROPE: STEM CELL MANUFACTURING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 42 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 43 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 45 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 46 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 47 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 48 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 49 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 50 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 51 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 52 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 53 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 54 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 55 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 56 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 57 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 58 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 59 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 60 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 61 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 62 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 63 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 64 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 65 UK: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 67 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 68 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 69 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 70 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 71 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 72 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 73 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 74 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 75 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 76 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 77 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 78 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 79 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES BY TYPE, 2018–2027 (USD MILLION)

TABLE 80 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS BY TYPE, 2018–2027 (USD MILLION)

TABLE 81 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 82 REST OF EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL-BASED THERAPY BY TYPE, 2018–2027 (USD MILLION)

TABLE 83 REST OF EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 84 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 85 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 86 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 87 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 88 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 89 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 90 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 91 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 92 CHINA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 93 CHINA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 94 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 95 CHINA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 96 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 97 INDIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 98 INDIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 99 INDIA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 100 INDIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 101 INDIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 102 INDIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 103 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 104 JAPAN: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 105 JAPAN: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 106 JAPAN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 107 JAPAN: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 108 JAPAN: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 109 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 110 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 111 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 112 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 113 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 114 SOUTH KOREA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 115 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 116 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 117 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 118 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 119 AUSTRALIA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 120 AUSTRALIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 121 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 123 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 124 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 125 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 126 REST OF ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 127 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 128 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 129 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 130 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 131 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 132 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 133 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 134 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 135 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 136 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 137 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 138 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 139 MIDDLE EAST: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 140 AFRICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 141 AFRICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 142 AFRICA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 143 AFRICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 144 AFRICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 145 AFRICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 146 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 147 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL LINES, BY TYPE, 2018–2027 (USD MILLION)

TABLE 148 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 149 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 150 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, FOR STEM CELL-BASED THERAPY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 151 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 152 MAJOR MANUFACTURERS IN STEM CELL MANUFACTURING MARKET

TABLE 153 MOST ACTIVE PLAYER IN STEM CELL MANUFACTURING MARKET

TABLE 154 PRODUCT APPROVALS AND PRODUCT LAUNCHES

TABLE 155 PARTNERSHIP/COLLABORATION

TABLE 156 BUSINESS EXPANSIONS/ AGREEMENTS

TABLE 157 MERGERS & ACQUISITIONS

TABLE 158 ABBVIE, INC.: PRODUCTS OFFERED

TABLE 159 ABBVIE, INC.: KEY DEVELOPMENTS

TABLE 160 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 161 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED

TABLE 162 FUJIFILM HOLDINGS CORPORATION: KEY DEVELOPMENTS

TABLE 163 BECTON DICKINSON AND COMPANY: PRODUCTS OFFERED

TABLE 164 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED

TABLE 165 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS

TABLE 166 LONZA GROUP: PRODUCTS OFFERED

TABLE 167 LONZA GROUP: KEY DEVELOPMENTS

TABLE 168 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS OFFERED

TABLE 169 BRISTOL-MYERS SQUIBB COMPANY: KEY DEVELOPMENTS

TABLE 170 GLAXOSMITH KLINE PLC: PRODUCTS OFFERED

TABLE 171 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS

TABLE 172 SARTORIUS AG: PRODUCTS OFFERED

TABLE 173 SARTORIUS AG: KEY DEVELOPMENTS

TABLE 174 MERCK KGAA: PRODUCTS OFFERED

TABLE 175 TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCTS OFFERED

TABLE 176 TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL STEM CELL MANUFACTURING MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF STEM CELL MANUFACTURING MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL STEM CELL MANUFACTURING MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL STEM CELL MANUFACTURING MARKET

FIGURE 9 GLOBAL STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: STEM CELL MANUFACTURING MARKET, BY END USER, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: STEM CELL MANUFACTURING MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: STEM CELL MANUFACTURING MARKET SHARE (%), BY REGION, 2020

FIGURE 14 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SHARE, BY COUNTRY 2020 (%)

FIGURE 15 EUROPE: STEM CELL MANUFACTURING MARKET SHARE, BY COUNTRY 2020 (%)

FIGURE 16 ASIA-PACIFIC: STEM CELL MANUFACTURING MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 17 REST OF THE WORLD: STEM CELL MANUFACTURING MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN STEM CELL MANUFACTURING MARKET

FIGURE 20 STEM CELL MANUFACTURING MARKET: COMPETITIVE LANDSCAPE

FIGURE 21 ABBVIE, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 ABBVIE, INC.: SWOT ANALYSIS

FIGURE 23 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 25 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 BOSTON DICKINSON AND COMPANY.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 29 LONZA GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 GLAXOSMITHKLINE PLC: SWOT ANALYSIS

FIGURE 33 SARTORIUS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 TAKEDA PHARMACEUTICAL COMPANY LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 TAKEDA PHARMACEUTICAL COMPANY LIMITED: SWOT ANALYSIS